NO20054911L - Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat - Google Patents

Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat

Info

Publication number: NO20054911L
Authority: NO; Norway
Prior art keywords: maleate; frosiglitazone; polymorphous; preparing; compound
Prior art date: 2003-03-28

Application number

NO20054911A

Other languages

English (en)

Norwegian (no)

Inventor

Robert Gordon Giles

Michael John Sasse

Andrew Simon Craig

Tim Chien Ting Ho

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-28

Filing date

2005-10-24

Publication date

2005-10-24

2005-10-24 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-10-24 Publication of NO20054911L publication Critical patent/NO20054911L/no

Links

VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 abstract 3
238000002360 preparation method Methods 0.000 abstract 3
229940125904 compound 1 Drugs 0.000 abstract 2
238000002425 crystallisation Methods 0.000 abstract 2
230000008025 crystallization Effects 0.000 abstract 2
AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 abstract 1
229960003271 rosiglitazone maleate Drugs 0.000 abstract 1
SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

NO20054911A 2003-03-28 2005-10-24 Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat NO20054911L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0307259.2A GB0307259D0 (en)	2003-03-28	2003-03-28	Process
PCT/GB2004/001306 WO2004085435A1 (fr)	2003-03-28	2004-03-25	Procede de preparation d'un polymorphe de maleate de rosiglitazone

Publications (1)

Publication Number	Publication Date
NO20054911L true NO20054911L (no)	2005-10-24

Family

ID=9955778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054911A NO20054911L (no)	2003-03-28	2005-10-24	Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat

Country Status (18)

Country	Link
US (1)	US20070167494A1 (fr)
EP (1)	EP1615918A1 (fr)
JP (1)	JP2006521340A (fr)
KR (1)	KR20050120670A (fr)
CN (1)	CN1768057A (fr)
AU (2)	AU2004224068A1 (fr)
BR (1)	BRPI0408752A (fr)
CA (1)	CA2520249A1 (fr)
EA (1)	EA009331B1 (fr)
EC (1)	ECSP056038A (fr)
GB (1)	GB0307259D0 (fr)
IS (1)	IS8087A (fr)
MA (1)	MA27727A1 (fr)
MX (1)	MXPA05010413A (fr)
NO (1)	NO20054911L (fr)
OA (1)	OA13042A (fr)
WO (1)	WO2004085435A1 (fr)
ZA (1)	ZA200507100B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
KR20230169457A (ko)	2017-01-27	2023-12-15	뉴로크린 바이오사이언시즈 인코퍼레이티드	특정 vmat2 억제제의 투여 방법
RS66714B1 (sr)	2017-09-21	2025-05-30	Neurocrine Biosciences Inc	Formulacija visoke doze valbenazina i sastavi, postupci i kompleti povezani sa njim
MX2020003421A (es)	2017-10-10	2020-07-20	Neurocrine Biosciences Inc	Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9723295D0 (en) *	1997-11-04	1998-01-07	Smithkline Beecham Plc	Novel process
PL351684A1 (en) *	1999-04-23	2003-06-02	Smithkline Beecham Plc	Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
HK1045152A1 (zh) *	1999-04-23	2002-11-15	Smithkline Beecham Plc	噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
AU765498B2 (en) *	1999-04-23	2003-09-18	Smithkline Beecham Plc	Novel pharmaceutical
MXPA03002580A (es) *	2000-09-26	2003-10-15	Cord Janet I	Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.

2003
- 2003-03-28 GB GBGB0307259.2A patent/GB0307259D0/en not_active Ceased
2004
- 2004-03-25 CN CNA2004800083916A patent/CN1768057A/zh active Pending
- 2004-03-25 EP EP04723254A patent/EP1615918A1/fr not_active Withdrawn
- 2004-03-25 JP JP2006506028A patent/JP2006521340A/ja not_active Withdrawn
- 2004-03-25 AU AU2004224068A patent/AU2004224068A1/en not_active Abandoned
- 2004-03-25 WO PCT/GB2004/001306 patent/WO2004085435A1/fr not_active Ceased
- 2004-03-25 CA CA002520249A patent/CA2520249A1/fr not_active Abandoned
- 2004-03-25 BR BRPI0408752-6A patent/BRPI0408752A/pt not_active IP Right Cessation
- 2004-03-25 OA OA1200500267A patent/OA13042A/en unknown
- 2004-03-25 KR KR1020057018143A patent/KR20050120670A/ko not_active Withdrawn
- 2004-03-25 EA EA200501527A patent/EA009331B1/ru unknown
- 2004-03-25 US US10/551,021 patent/US20070167494A1/en not_active Abandoned
- 2004-03-25 MX MXPA05010413A patent/MXPA05010413A/es unknown
2005
- 2005-09-05 ZA ZA200507100A patent/ZA200507100B/en unknown
- 2005-09-26 EC EC2005006038A patent/ECSP056038A/es unknown
- 2005-10-11 MA MA28549A patent/MA27727A1/fr unknown
- 2005-10-24 NO NO20054911A patent/NO20054911L/no not_active Application Discontinuation
- 2005-10-24 IS IS8087A patent/IS8087A/is unknown
2008
- 2008-10-30 AU AU2008237610A patent/AU2008237610A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20050120670A (ko)	2005-12-22
CA2520249A1 (fr)	2004-10-07
OA13042A (en)	2006-11-10
JP2006521340A (ja)	2006-09-21
MXPA05010413A (es)	2005-11-04
EP1615918A1 (fr)	2006-01-18
ZA200507100B (en)	2006-07-26
GB0307259D0 (en)	2003-05-07
US20070167494A1 (en)	2007-07-19
IS8087A (is)	2005-10-24
EA200501527A1 (ru)	2006-02-24
WO2004085435A1 (fr)	2004-10-07
CN1768057A (zh)	2006-05-03
BRPI0408752A (pt)	2006-03-28
ECSP056038A (es)	2006-01-27
AU2004224068A1 (en)	2004-10-07
EA009331B1 (ru)	2007-12-28
MA27727A1 (fr)	2006-01-02
AU2008237610A1 (en)	2008-11-27

Similar Documents

Publication	Publication Date	Title
EA200701358A1 (ru)	2007-12-28	Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
NO2013008I2 (no)	2013-10-21	Krizotinib eller et farmasøytisk akseptabelt salt, hydrat eller solvat derav
TNSN06069A1 (en)	2007-10-03	Polymorphous forms of rifaximin as antibiotics
BR0213931A (pt)	2004-09-08	Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
NO20054852L (no)	2005-12-13	GFAT inhibitorer
IL183700A0 (en)	2007-09-20	Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
NO20062020L (no)	2006-07-10	1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
ZA200801890B (en)	2009-11-25	Novel crystalline form of a pyridazino (4, 5-B) indole derivative
WO2004043920A8 (fr)	2005-07-21	Polymorphes du chlorhydrate de bicifadine
NO20063576L (no)	2006-10-06	1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
NO20051047L (no)	2005-04-28	Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
WO2002092602A3 (fr)	2003-02-27	Procedes de synthese de derives de 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
MXPA05010413A (es)	2005-11-04	Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.
NO20062599L (no)	2006-06-06	Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
WO2005000242A3 (fr)	2007-08-23	Procede d'obtention de l'acide 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyrique, polymorphe de forme a
FR2858620B1 (fr)	2006-11-17	Cristallisation a haute temperature du 2,4,6,8,10,12 -hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0 0]- dodecane
IL163520A0 (en)	2005-12-18	Process for preparing crystalline form i of cabergoline
WO2002072567A3 (fr)	2002-11-28	Nouveaux composes heterocycliques utiles dans le traitement des troubles allergiques inflammatoires; procede de leur preparation et compositions pharmaceutiques les contenant
SG149005A1 (en)	2009-01-29	Process for the preparation of thiazolopyrimidines
IL163779A0 (en)	2005-12-18	Process for preparing crystalline form i of cabergoline
NO20050885D0 (no)	2005-02-18	Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
WO2004096765A3 (fr)	2005-01-27	Nouvelle forme polymorphe cristalline du sodium de fluvastatine et procede de preparation associe
WO2004069790A3 (fr)	2005-02-17	Modification cristalline
AU2003222399A1 (en)	2004-11-26	Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides
NO20060922L (no)	2006-02-24	Ny fremgangsmate for syntesen av perindopril og dens farmasoytiske akseptable salter

Legal Events

Date	Code	Title	Description
2010-11-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application